Ocular Shakes Investor Suit Over FDA Approval Of Eye Drug
Ocular Therapeutix Inc. escaped a proposed class action Tuesday after a Massachusetts federal judge found that the investors who accuse the biopharmaceutical company of misleading them about federal approval for an...To view the full article, register now.
Already a subscriber? Click here to view full article